Video

The Curative Potential of CAR-T Cell Therapy in Mantle Cell Lymphoma

Author(s):

Andre Goy, M.D., M.S.

Though it is still being tested in clinical trials, CAR-T cell therapy can offer hope for patients with mantle cell lymphoma whose disease relapsed.

Chimeric antigen receptor (CAR)-T cell therapy is generating excitement across blood cancers, and may eventually be an appealing option for patients with mantle cell lymphoma (MCL), said Andre Goy, M.D., M.S., chief, Division of Lymphoma, chairman and director of the John Theurer Cancer Center.

The ongoing ZUMA-2 trial is exploring the possibility of CAR-T cell therapy in patients with relapsed or refractory MCL. While official results are not out yet, Goy mentioned that the researchers are seeing a high response rate and promising results in this patient population.

Goy said that CAR-T cell therapy is particularly appealing in patients with MCL who eventually develop a resistance to chemotherapy. CAR-T cells can offer a new line of therapy in a setting that traditionally had very few options.

Related Videos
Image of a woman with long red hair.
Image of a man in a suit.
Image of woman with brown hair.
Image of a man with short hair, wearing a buttoned-up shirt.
Image of a man with short black hair.
Image of a woman with tied back hair, wearing pearl earrings.
Image of a woman with layered hair, wearing a bright blue cardigan.
Image of a man with short black hair.
Image of man with gray hair.
Related Content
Picture of Dr. Guillermo Garcia-Manero
September 18th 2024

Why Transfusion Independence Matters for Patients With MDS

Alex Biese
An expert explained the burden that red blood cell transfusions can place on patients with MDS.
Image of "FDA Approved" in red.
September 6th 2024

Boruzu Approved by FDA For Multiple Myeloma, Mantle Cell Lymphoma

Alex Biese
Boruzu, an injectable presentation of Velcade, has been approved by the FDA for patients who either have multiple myeloma or mantle cell lymphoma.
Illustration of a woman with long blonde hair, wearing sunglasses.
August 26th 2024

8 Things to Do While in the Hospital for Cancer Treatment

Mary Sansone
While spending weeks in the hospital for acute myeloid leukemia, I tried eight fun things to keep me busy.
Image of lymphoma cells.
July 24th 2024

CAR-T Cell Therapy for Relapsed, Refractory Mantle Cell Lymphoma Fills Unmet Need

Ashley Chan
Treating patients with CAR-T cell therapy Breyanzi may change the paradigm for those with relapsed or refractory mantle cell lymphoma, an expert said.
Image of a man wearing a light blue polo shirt.
July 18th 2024

Radiation a Curative-Intent Option in NSCLC and Interstitial Lung Disease

Alex Biese
For some patients with early non-small cell lung cancer and lung scarring, stereotactic ablative radiotherapy may be a viable option, research has shown.
Finding a Second Opinion Was a Pivotal Moment in My Cancer Experience
July 18th 2024

Finding a Second Opinion Was a Pivotal Moment in My Cancer Experience

Jim Maloney
From second opinions to research and asking for help, here are some pivotal lessons I learned after a mantle cell lymphoma diagnosis.